Company news

Theravance Biopharma, Inc. news in 2021

Theravance Biopharma, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Theravance Biopharma, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

November 2, 2021

Theravance Biopharma to Report Third Quarter 2021 Financial Results November 3, 2021

October 19, 2021

Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

September 14, 2021

Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio

September 14, 2021

Theravance Biopharma, Inc. Announces Top-line Results from Phase 2b Dose-Finding Induction Study of Izencitinib in Patients with Ulcerative Colitis

August 22, 2021

Theravance Biopharma, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

August 2, 2021

Theravance Biopharma to Report Second Quarter 2021 Financial Results on August 3, 2021

July 19, 2021

Theravance Biopharma, Inc. Announces Proposed Public Offering of Ordinary Shares

June 23, 2021

Theravance Biopharma, Inc. Announces Pricing of Public Offering of Ordinary Shares

June 23, 2021

Theravance Biopharma, Inc. Announces Top-Line Results From Phase 2 Study of Nezulcitinib In Patients Hospitalized With Acute Lung Injury Due to COVID-19

June 20, 2021

Theravance Biopharma, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

May 3, 2021

Theravance Biopharma to Report First Quarter 2021 Financial Results on May 4, 2021

April 19, 2021

Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

February 22, 2021

Theravance Biopharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 23, 2021

February 8, 2021

Theravance Biopharma To Present at the 39th Annual J.P. Morgan Healthcare Conference

January 4, 2021

Calls in 2021

Decks in 2021